Human chorionic gonadotropin free β-subunit measurement as a marker of placental site trophoblastic tumors

Journal of Reproductive Medicine for the Obstetrician and Gynecologist

Volumn 53, Issue 8, 2008, Pages 643-648

  Harvey, Richard A ^a,b   Pursglove, Howard D ^a   Schmid, Peter ^a   Savage, Philip M ^a   Mitchell, Hugh D C ^a   Seckl, Michael J ^a  

^a Trophoblastic Disease Centre   (United Kingdom)

^b CHARING CROSS HOSPITAL   (United Kingdom)

Author keywords

Free human chorionic gonadotropin subunit; Gestational trophoblastic disease; Placental site trophoblastic

Indexed keywords

CHORIONIC GONADOTROPIN BETA SUBUNIT;

ADULT; ARTICLE; CHORIOCARCINOMA; CONTROLLED STUDY; FALSE POSITIVE RESULT; FEMALE; HORMONE BLOOD LEVEL; HUMAN; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; RADIOIMMUNOASSAY; RECEIVER OPERATING CHARACTERISTIC;

ADULT; CHORIONIC GONADOTROPIN, BETA SUBUNIT, HUMAN; COHORT STUDIES; FEMALE; HUMANS; PREGNANCY; ROC CURVE; TROPHOBLASTIC TUMOR, PLACENTAL SITE; TUMOR MARKERS, BIOLOGICAL; UTERINE NEOPLASMS;

EID: 51549100807     PISSN: 00247758     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (15)

1. Palmieri C, Fisher RA, Sebire NJ, et al: Placental site trophoblastic tumour arising from a partial hydatidiform mole. Lancet 2005;366:688
2. Fisher RA, Paradinas FJ, Newlands ES, et al: Genetic evidence that placental site trophoblastic tumours can originate from a hydatidiform mole or a normal conceptus. Br J Cancer 1992;65:355-358
3. Paradinas FJ, Sebire NJ, Rees HC: Pathology. In Gestational Trophoblastic Disease. Edited by BW Hancock, ES Newlands, RS Berkowitz, et al. Sheffield, U.K., Sheffield University Press, 2003, pp 77-129
4. Papadopoulos AJ, Foskett M, Seckl MJ, et al: Twenty-five years' clinical experience with placental site trophoblastic tumors. J Reprod Med 2002;47:460-464
5. Cole LA, Khanlian SA, Muller CY, et al: Gestational trophoblastic diseases: III. Human chorionic gonadotropin free β-subunit, a reliable marker of placental site trophoblastic tumors. Gynecol Oncol 2006;102:160-164
6. Berger P, Sturgeon C, Bidart JM, et al: The ISOBM TD-7 Workshop on hCG and related molecules: Towards user-oriented standardization of pregnancy and tumor diagnosis: Assignment of epitopes to the three-dimensional structure of diagnostically and commercially relevant monoclonal antibodies directed against human chorionic gonadotropin and derivatives. Tumour Biol 2002;23:1-38
7. Stoning PL, Gaines-Das RE, Bangham DR: International reference preparation of human chorionic gonadotrophin for immunoassay: Potency estimates in various bioassay and protein binding assay systems; and International Reference Preparations of the alpha and beta subunits of human chorionic gonadotrophin for immunoassay. J Endocrinol 1990;84:295-310
8. Stenman UH, Tiitinen A, Alfthan H, et al: The classification, functions and clinical use of different isoforms of hCG. Hum Reprod Update 2006;12:769-784
9. Ozrurk M, Berkowitz R, Goldstein D, et al: Differential production of human chorionic gonadotropin and free subunits in gestational trophoblastic disease. Am J Obstet Gynecol 1988;158:193-198
10. Khazaeli MB, Buchina ES, Patrillo RA, et al: Radioimmunoassay of free beta-subunit of human chorionic gonadotropin in diagnosis of high-risk and low-risk gestational trophoblastic disease. Am J Obstet Gynecol 1989;160:444-449
11. Vartiainen J, Alfthan H, Lehtovirta P, et al: Identification of choriocarcinoma by the hCG beta-to-hCG proportion in patients with delayed diagnosis caused by contraceptive use. Contraception 1998;57:257-260
12. Hotakainen K, Ljungberg B, Paju A, et al: The free beta-subunit of human chorionic gonadotropin as a prognostic factor in renal cell carcinoma. Br J Cancer 2002;86:185-189
13. Louhimo J, Carpelan-Holmström M, Alfthan H, et al: Serum HCG beta, CA 72-4 and CEA are independent prognostic factors in colorectal cancer. Int J Cancer 2002;101:545-548
14. Louhimo J, Finne P, Alfthan H, et al: Combination of HCG-beta, CA 19-9 and CEA with logistic regression improves accuracy in gastrointestinal malignancies. Anticancer Res 2002;22:1759-1764
15. Alfthan H, Haglund C, Roberts P, et al: Elevation of free β-subunit of human choriogonadotropin and core β fragment of choriogonadotropin in the serum and urine of patients with malignant pancreatic and biliary disease. Cancer Res 1992;52:4628-4633